The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
Open accessAbstract
Objective: To provide healthcare professionals with updated guidance in the use of novel preventive and acute treatments for migraine in adults. Background: The principles of preventive and acute pharmacotherapy for patients with migraine have been outlined previously, but the emergence of new technologies and treatments, as well as new formulations of previously established treatments, has created a need for an updated guidance on the preventive and acute treatment of migraine. Methods: This statement is based on a review of existing guidelines and principles for preventive and acute treatment of migraine, as well as the results of recent clinical trials of drugs and devices for these indications. Input was sought from health insurance providers, employers, pharmacy benefit service companies, device manufacturers, pharmaceutical and biotechnology companies, patients, and patient advocates. Expert clinicians and researchers in the field of headache medicine from across North America and the European Union provided input and feedback. Results: The principles of pharmacologic preventive treatment of migraine with oral treatments have been as follows: use evidence‐based treatments when possible and appropriate; start with a low dose and titrate slowly; reach a therapeutic dose if possible; allow for an adequate treatment trial duration; establish expectations of therapeutic response and adverse events; and maximize adherence. Newer injectable treatments may work faster and may not need titration. The principles of acute treatment include: use evidence‐based treatments when possible and appropriate; treat early after the onset of a migraine attack; choose a nonoral route of administration for selected patients; account for tolerability and safety issues; consider self‐administered rescue treatments; and avoid overuse of acute medications. Neuromodulation and biobehavioral therapy may be appropriate for preventive and acute treatment, depending on the needs of individual patients. Neuromodulation may be useful for patients who prefer nondrug therapies or who respond poorly, cannot tolerate, or have contraindications to pharmacotherapy. Conclusions: This statement updates prior recommendations and outlines the indications for initiating, continuing, combining, and switching preventive and acute treatments of migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument
Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993) · PharmacoEconomics · doi:10.2165/00019053-199304050-00006 · Cited by 3,071
Migraine prevalence, disease burden, and the need for preventive therapy
Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007) · Neurology · doi:10.1212/01.wnl.0000252808.97649.21 · Cited by 2,337
Feigin, V. L., Abajobir, A. A., Abate, K. H., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Abyu, G. Y., Ahmed, M. B., Aichour, A. N., Aichour, I., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30299-5 · Cited by 2,275
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268
Stewart, W. F. (1992) · JAMA · doi:10.1001/jama.267.1.64 · Cited by 1,583
Quantifying the burden of disease: the technical basis for disability-adjusted life years.
Murray, C. J. L. (1994) · Europe PMC (PubMed Central) · Cited by 1,581
Silberstein, S. D. (2000) · Neurology · doi:10.1212/wnl.55.6.754 · Cited by 1,360
Stewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (2001) · Neurology · doi:10.1212/wnl.56.suppl_1.s20 · Cited by 1,210
Aurora, S., Dodick, D., Turkel, C., DeGryse, R., Silberstein, S., Lipton, R., Diener, H., & Brin, M. (2010) · Cephalalgia · doi:10.1177/0333102410364676 · Cited by 1,047
An association between migraine and cutaneous allodynia
Burstein, R., Yarnitsky, D., Goor-Aryeh, I., Ransil, B. J., & Bajwa, Z. H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<614::aid-ana9>3.0.co;2-n · Cited by 1,016
Diener, H., Dodick, D., Aurora, S., Turkel, C., DeGryse, R., Lipton, R., Silberstein, S., & Brin, M. (2010) · Cephalalgia · doi:10.1177/0333102410364677 · Cited by 960
A Controlled Trial of Erenumab for Episodic Migraine
Goadsby, P. J., Reuter, U., Hallström, Y., Broessner, G., Bonner, J. H., Zhang, F., Sapra, S., Picard, H., Mikol, D. D., & Lenz, R. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1705848 · Cited by 928
Silberstein, S. D., Holland, S., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012) · Neurology · doi:10.1212/wnl.0b013e3182535d20 · Cited by 897
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
Bigal, M. E., Serrano, D., Buse, D., Scher, A., Stewart, W. F., & Lipton, R. B. (2008) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01217.x · Cited by 845
Fremanezumab for the Preventive Treatment of Chronic Migraine
Silberstein, S. D., Dodick, D. W., Bigal, M. E., Yeung, P. P., Goadsby, P. J., Blankenbiller, T., Grozinski-Wolff, M., Yang, R., Ma, Y., & Aycardi, E. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1709038 · Cited by 792
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition
International Headache Society Clinical Trials Subcommittee, Tfelt-Hansen, P., Block, G., Dahlöf, C., Diener, H.-C., Ferrari, M., Goadsby, P., Guidetti, V, Jones, B., Lipton, R., et al. (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.00117.x · Cited by 698
Cutaneous allodynia in the migraine population
Lipton, R. B., Bigal, M. E., Ashina, S., Burstein, R., Silberstein, S., Reed, M. L., Serrano, D., Stewart, W. F., & American Migraine Prevalence Prevention Advisory Group (2008) · Annals of Neurology · doi:10.1002/ana.21211 · Cited by 598
Marmura, M. J., Silberstein, S. D., & Schwedt, T. J. (2015) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12499 · Cited by 568
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
Dodick, D. W., Ashina, M., Brandes, J. L., Kudrow, D., Lanteri-Minet, M., Osipova, V., Palmer, K., Picard, H., Mikol, D. D., & Lenz, R. A. (2018) · Cephalalgia · doi:10.1177/0333102418759786 · Cited by 566
Stauffer, V. L., Dodick, D. W., Zhang, Q., Carter, J. N., Ailani, J., & Conley, R. R. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1212 · Cited by 559
Adherence to oral migraine-preventive medications among patients with chronic migraine
Hepp, Z., Dodick, D. W., Varon, S. F., Gillard, P., Hansen, R. N., & Devine, E. B. (2015) · Cephalalgia · doi:10.1177/0333102414547138 · Cited by 433
Tassorelli, C., Diener, H.-C., Dodick, D. W., Silberstein, S. D., Lipton, R. B., Ashina, M., Becker, W. J., Ferrari, M. D., Goadsby, P. J., Pozo-Rosich, P., et al. (2018) · Cephalalgia · doi:10.1177/0333102418758283 · Cited by 388
Blumenfeld, A. M., Bloudek, L. M., Becker, W. J., Buse, D. C., Varon, S. F., Maglinte, G. A., Wilcox, T. K., Kawata, A. K., & Lipton, R. B. (2013) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12055 · Cited by 380
Dodick, D. W., Goadsby, P. J., Silberstein, S. D., Lipton, R. B., Olesen, J., Ashina, M., Wilks, K., Kudrow, D., Kroll, R., Kohrman, B., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70209-1 · Cited by 372
Dodick, D. W., Goadsby, P. J., Spierings, E. L. H., Scherer, J. C., Sweeney, S. P., & Grayzel, D. S. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70128-0 · Cited by 368
Sun, H., Dodick, D. W., Silberstein, S., Goadsby, P. J., Reuter, U., Ashina, M., Saper, J., Cady, R., Chon, Y., Dietrich, J., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00019-3 · Cited by 358
Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine
Lipton, R. B., Fanning, K. M., Serrano, D., Reed, M. L., Cady, R., & Buse, D. C. (2015) · Neurology · doi:10.1212/wnl.0000000000001256 · Cited by 315
Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults
Silberstein, S., Tfelt-Hansen, P., Dodick, D., Limmroth, V, Lipton, R., Pascual, J., Wang, S., & for the Task Force of the International Headache Society Clinical Trials Subcommittee (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01555.x · Cited by 303
Munakata, J., Hazard, E., Serrano, D., Klingman, D., Rupnow, M. F. T., Tierce, J., Reed, M., & Lipton, R. B. (2009) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2009.01369.x · Cited by 299
Bigal, M. E., Dodick, D. W., Rapoport, A. M., Silberstein, S. D., Ma, Y., Yang, R., Loupe, P. S., Burstein, R., Newman, L. C., & Lipton, R. B. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00249-5 · Cited by 287
Canadian Headache Society guideline for migraine prophylaxis.
Pringsheim, T. M., Davenport, W. J., Mackie, G. F., Worthington, I., Aubé, M., Christie, S. N., Gladstone, J. P., & Becker, W. J. (2012) · PubMed · Cited by 278
Silberstein, S. D. (2015) · Continuum · doi:10.1212/con.0000000000000199 · Cited by 278
Cutaneous allodynia as a predictor of migraine chronification
Louter, M. A., Bosker, J. E., van Oosterhout, W. P. J., van Zwet, E. W., Zitman, F. G., Ferrari, M. D., & Terwindt, G. M. (2013) · Brain · doi:10.1093/brain/awt251 · Cited by 278
Biofeedback Treatment for Headache Disorders: A Comprehensive Efficacy Review
Nestoriuc, Y., Martin, A., Rief, W., & Andrasik, F. (2008) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-008-9060-3 · Cited by 273
Bigal, M. E., Edvinsson, L., Rapoport, A. M., Lipton, R. B., Spierings, E. L. H., Diener, H.-C., Burstein, R., Loupe, P. S., Ma, Y., Yang, R., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00245-8 · Cited by 261
Buse, D., Manack, A., Serrano, D., Reed, M., Varon, S., Turkel, C., & Lipton, R. (2012) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.02046.x · Cited by 239
Serrano, D., Lipton, R. B., Scher, A. I., Reed, M. L., Stewart, W. F., Adams, A. M., & Buse, D. C. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0787-1 · Cited by 227
Holroyd, K. A., Cottrell, C. K., O'Donnell, F. J., Cordingley, G. E., Drew, J. B., Carlson, B. W., & Himawan, L. (2010) · BMJ · doi:10.1136/bmj.c4871 · Cited by 222
Buse, D. C., Scher, A. I., Dodick, D. W., Reed, M. L., Fanning, K. M., Manack Adams, A., & Lipton, R. B. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.02.013 · Cited by 197
Skljarevski, V., Oakes, T. M., Zhang, Q., Ferguson, M. B., Martinez, J., Camporeale, A., Johnson, K. W., Shan, Q., Carter, J., Schacht, A., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3859 · Cited by 172
Starling, A. J., Tepper, S. J., Marmura, M. J., Shamim, E. A., Robbins, M. S., Hindiyeh, N., Charles, A. C., Goadsby, P. J., Lipton, R. B., Silberstein, S. D., et al. (2018) · Cephalalgia · doi:10.1177/0333102418762525 · Cited by 162
Validating Migraine‐Specific Quality of Life Questionnaire v2.1 in Episodic and Chronic Migraine
Bagley, C. L., Rendas‐Baum, R., Maglinte, G. A., Yang, M., Varon, S. F., Lee, J., & Kosinski, M. (2012) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01997.x · Cited by 160
Coeytaux, R. R., Kaufman, J. S., Chao, R. A., Mann, J. D., & DeVellis, R. F. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.05.010 · Cited by 154
Non-Pharmacological Approaches for Migraine
Puledda, F., & Shields, K. G. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0623-6 · Cited by 143
Premonitory symptoms in migraine: A cross-sectional study in 2714 persons
Laurell, K., Artto, V., Bendtsen, L., Hagen, K., Häggström, J., Linde, M., Söderström, L., Tronvik, E., Wessman, M., Zwart, J., et al. (2015) · Cephalalgia · doi:10.1177/0333102415620251 · Cited by 138
Serrano, D., Manack, A. N., Reed, M. L., Buse, D. C., Varon, S. F., & Lipton, R. B. (2013) · Value in Health · doi:10.1016/j.jval.2012.08.2212 · Cited by 130
(1990) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1990.tb00847.x · Cited by 126
Validity and Reliability of the Migraine-Treatment Optimization Questionnaire
Lipton, R. B., Kolodner, K., Bigal, M., Valade, D., Lainez, M., Pascual, J., Gendolla, A., Bussone, G., Islam, N., Albert, K. S., et al. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01786.x · Cited by 118
Harris, P., Loveman, E., Clegg, A. J., Easton, S., & Berry, N. (2015) · British Journal of Pain · doi:10.1177/2049463715578291 · Cited by 111
Silberstein, S. D., Dodick, D. W., Freitag, F. G., Pearlman, S. H., Hahn, S. R., Scher, I., & Lipton, R. B. (2007) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2007.00760.x · Cited by 94
Biofeedback in headache: An overview of approaches and evidence
Andrasik, F. (2010) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.77.s3.13 · Cited by 90
Mannix, S., Skalicky, A. M., Buse, D. C., Desai, P., Sapra, S. J., Ortmeier, B. G., Widnell, K. L., & Hareendran, A. (2016) · Health and Quality of Life Outcomes · doi:10.1186/s12955-016-0542-3 · Cited by 89
The Impact of Topiramate on Health‐Related Quality of Life Indicators in Chronic Migraine
Dodick, D. W., Silberstein, S. D., Saper, J. R., Freitag, F. G., Cady, R. K., Rapoport, A. M., Mathew, N. T., Hulihan, J. F., Crivera, C., Rupnow, M. F. T., et al. (2007) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2007.00950.x · Cited by 83
Revised French guidelines for the diagnosis and management of migraine in adults and children
Lantéri‐Minet, M., Valade, D., Geraud, G. E. A., Lucas, C., & Donnet, A. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-2 · Cited by 82
Holroyd, K. A., & Penzien, D. B. (1994) · Behavioral Medicine · doi:10.1080/08964289.1994.9934617 · Cited by 78
Smelt, A. F., Louter, M. A., Kies, D. A., Blom, J. W., Terwindt, G. M., van der Heijden, G. J. M. G., Gucht, V. D., Ferrari, M. D., & Assendelft, W. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098933 · Cited by 78
Dodick, D., & Silberstein, S. D. (2007) · Practical Neurology · doi:10.1136/jnnp.2007.134023 · Cited by 77
Headaches in over 12s: diagnosis and management
Crosland, P. (2015) · Deakin Research Online (Deakin University) · Cited by 76
Cady, R. K., McAllister, P. J., Spierings, E. L. H., Messina, J. C., Carothers, J. L., Djupesland, P. G., & Mahmoud, R. A. (2014) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12472 · Cited by 68
National Trends in Direct Health Care Expenditures Among US Adults With Migraine: 2004 to 2013
Raval, A. D., & Shah, A. (2016) · Journal of Pain · doi:10.1016/j.jpain.2016.10.005 · Cited by 68
Chou, D. E., Gross, G. J., Casadei, C. H., & Yugrakh, M. S. (2017) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12623 · Cited by 67
Dowson, A. J., Tepper, S. J., Baos, V., Baudet, F., D’Amico, D., & Kilminster, S. G. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125004079 · Cited by 63
Tepper, S. J., Cady, R. K., Silberstein, S. D., Messina, J. C., Mahmoud, R. A., Djupesland, P. G., Shin, P., & Siffert, J. O. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12583 · Cited by 55
Acute Migraine Treatment: Patterns of Use and Satisfaction in a Clinical Population
Malik, S. N., Hopkins, M. M., Young, W. B., & Silberstein, S. D. (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00437.x · Cited by 53
Fremanezumab as Add‐On Treatment for Patients Treated With Other Migraine Preventive Medicines
Cohen, J. M., Dodick, D. W., Yang, R., Newman, L. C., Li, T., Aycardi, E., & BIGAL, M. E. (2017) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13156 · Cited by 50
Kawata, A. K., Hsieh, R., Bender, R. H., Shaffer, S., Revicki, D. A., Bayliss, M. S., Buse, D. C., Desai, P., Sapra, S. J., Ortmeier, B. G., et al. (2017) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13162 · Cited by 44
Acute Migraine Treatment Outcome Measures: A Clinician's View
Sheftell, F., & Fox, A. (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.0200s2014.x · Cited by 42
Revicki, D. A., Kimel, M., Beusterien, K., Kwong, J. W., Varner, J., Ames, M. H., Mahajan, S., & Cady, R. K. (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00289.x · Cited by 41
Cousins, S., Ridsdale, L., Goldstein, L. H., Noble, A. J., Moorey, S., & Seed, P. T. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7916-z · Cited by 39
Drug safety in acute migraine treatment
Tajti, J., Majláth, Z., Szok, D., Csáti, A., & Vécsei, L. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1026325 · Cited by 38
Katsarava, Z., Holle, D., & Diener, H. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0019-4 · Cited by 33
Cady, R. K., Munjal, S., Cady, R. J., Manley, H. R., & Brand‐Schieber, E. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0717-7 · Cited by 33
Munjal, S., Brand‐Schieber, E., Allenby, K. S., et al. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0740-3 · Cited by 25
Silberstein, S. D., Cady, R. K., Sheftell, F. D., Almas, M., Parsons, B., & Albert, K. S. (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00633.x · Cited by 24
Cited by
Ashina, M. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1915327 · Cited by 816
Ailani, J., Burch, R. C., Robbins, M. S., & the Board of Directors of the American Headache Society (2021) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.14153 · Cited by 766
Atogepant for the Preventive Treatment of Migraine
Ailani, J., Lipton, R. B., Goadsby, P. J., Guo, H., Miceli, R., Severt, L., Finnegan, M., & Trugman, J. M. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035908 · Cited by 312
Migraine: integrated approaches to clinical management and emerging treatments
Ashina, M., Buse, D. C., Ashina, H., Pozo-Rosich, P., Peres, M. F. P., Lee, M. J., Terwindt, G. M., Halker Singh, R., Tassorelli, C., Do, T. P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32342-4 · Cited by 305
Targeting calcitonin gene-related peptide: a new era in migraine therapy
Charles, A., & Pozo-Rosich, P. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32504-8 · Cited by 304
Metadata
- Authors
- American Headache Society
- Venue
- Headache: The Journal of Head and Face Pain
- Publisher
- Wiley
- Published
- 2018-12-10
- Volume
- 59
- Issue
- 1
- Pages
- 1-18
- ISSN
- 0017-8748 (ISSN-L)
- 1526-4610
- OpenAlex
- W4244823958
- Cited by
- 567
- References
- 76
- FWCI
- 43.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.